Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Neurological Biomarkers Market, by Type
1.4.2 Asia Pacific Neurological Biomarkers Market, by Application
1.4.3 Asia Pacific Neurological Biomarkers Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Neurological Biomarkers Market by Type
3.1 Asia Pacific Proteomic Market by Country
3.2 Asia Pacific Genomic Market by Country
3.3 Asia Pacific Metabolomic Market by Country
3.4 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Neurological Biomarkers Market by Application
4.1 Asia Pacific Alzheimer's Disease Market by Country
4.2 Asia Pacific Parkinson’s Disease Market by Country
4.3 Asia Pacific Multiple Sclerosis Market by Country
Chapter 5. Asia Pacific Neurological Biomarkers Market by Country
5.1 China Neurological Biomarkers Market
5.1.1 China Neurological Biomarkers Market by Type
5.1.2 China Neurological Biomarkers Market by Application
5.2 Japan Neurological Biomarkers Market
5.2.1 Japan Neurological Biomarkers Market by Type
5.2.2 Japan Neurological Biomarkers Market by Application
5.3 India Neurological Biomarkers Market
5.3.1 India Neurological Biomarkers Market by Type
5.3.2 India Neurological Biomarkers Market by Application
5.4 Australia Neurological Biomarkers Market
5.4.1 Australia Neurological Biomarkers Market by Type
5.4.2 Australia Neurological Biomarkers Market by Application
5.5 South Korea Neurological Biomarkers Market
5.5.1 South Korea Neurological Biomarkers Market by Type
5.5.2 South Korea Neurological Biomarkers Market by Application
5.6 Singapore Neurological Biomarkers Market
5.6.1 Singapore Neurological Biomarkers Market by Type
5.6.2 Singapore Neurological Biomarkers Market by Application
5.7 Rest of Asia Pacific Neurological Biomarkers Market
5.7.1 Rest of Asia Pacific Neurological Biomarkers Market by Type
5.7.2 Rest of Asia Pacific Neurological Biomarkers Market by Application
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Merck Group
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
6.4.1 Company Overview
6.4.1 Financial Analysis
6.4.2 Segmental and Regional Analysis
6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 BioMérieux S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
6.10.1 Company Overview
Unique Offerings 